BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment

On February 26, BeOne Medicines AG (NASDAQ:ONC) reported full planetary revenues of $1.5 cardinal for the 4th fourth of 2025 and $5.3 cardinal for 2026, increases of 33% and 40% from the prior-quarter and prior-year periods, respectively. Brukinsa, the company’s lymphoma and leukemia treatment, had revenues of $1.1 cardinal and $3.9 cardinal for the 4th fourth and afloat year, respectively, up 38% and 49% from the anterior periods.

After the net report, connected February 27, Truist Securities raised its terms people connected BeOne Medicines AG (NASDAQ:ONC) to $412 from $400 portion maintaining a Buy standing connected the stock. Truist adjusted its terms people aft incorporating the quarterly results, fiscal 2026 guidance, and insights from post-earnings discussions with the company.

Truist Securities noted BeOne Medicines AG (NASDAQ:ONC)’s fiscal 2026 gross guidance of $6.2 cardinal to $6.4 cardinal astir brackets statement estimates of $6.4 cardinal and has led to added unit connected the shares. The expert said that its existent outlook connected BeOne Medicines AG (NASDAQ:ONC) suggests steadfast maturation for Brukinsa adjacent without immoderate large statement expansion.

Grail Inc.'s Galleri crab trial screening kit. Photo from Grail website

BeOne Medicines AG (NASDAQ:ONC) is simply a planetary oncology institution that discovers and develops innovative treatments that are much affordable and accessible to crab patients worldwide.

While we admit the imaginable of ONC arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 13 Hot Stocks to Buy with the Highest Upside Potential and 10 Best High-Upside Materials Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.